Company / Net Income
ADC Therapeutics SA Net Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$142.6M
FY2025
5-year range
-$240.1M / -$142.6M
FY2023-FY2025
Trend
+40.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$157M to -$143M over the past 2 years.
Based on SEC 10-K filings.
-$143M in FY2025.
Improved from -$157M to -$143M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 40.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$142.6M | +40.6% |
| FY2024 | -$240.1M | -52.8% |
| FY2023 | -$157.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026